1. Lamin A/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model.
- Author
-
Qiu H, Sun Y, Wang X, Gong T, Su J, Shen J, Zhou J, Xia J, Wang H, Meng X, Fu G, Zhang D, Jiang C, and Liang P
- Subjects
- Humans, Phenotype, Arrhythmias, Cardiac metabolism, Arrhythmias, Cardiac genetics, Arrhythmias, Cardiac pathology, Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism, Calcium-Calmodulin-Dependent Protein Kinase Type 2 genetics, Frameshift Mutation, Calcium metabolism, Ryanodine Receptor Calcium Release Channel metabolism, Ryanodine Receptor Calcium Release Channel genetics, Nuclear Envelope metabolism, Mitochondria metabolism, Male, Microtubule-Associated Proteins metabolism, Microtubule-Associated Proteins genetics, Cardiomyopathy, Dilated metabolism, Cardiomyopathy, Dilated genetics, Cardiomyopathy, Dilated pathology, Lamin Type A metabolism, Lamin Type A genetics, Induced Pluripotent Stem Cells metabolism, Reactive Oxygen Species metabolism, Sirtuin 1 metabolism, Sirtuin 1 genetics, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Oxidative Stress
- Abstract
Mutations in the nuclear envelope (NE) protein lamin A/C (encoded by LMNA), cause a severe form of dilated cardiomyopathy (DCM) with early-onset life-threatening arrhythmias. However, molecular mechanisms underlying increased arrhythmogenesis in LMNA-related DCM (LMNA-DCM) remain largely unknown. Here we show that a frameshift mutation in LMNA causes abnormal Ca
2+ handling, arrhythmias and disformed NE in LMNA-DCM patient-specific iPSC-derived cardiomyocytes (iPSC-CMs). Mechanistically, lamin A interacts with sirtuin 1 (SIRT1) where mutant lamin A/C accelerates degradation of SIRT1, leading to mitochondrial dysfunction and oxidative stress. Elevated reactive oxygen species (ROS) then activates the Ca2+ /calmodulin-dependent protein kinase II (CaMKII)-ryanodine receptor 2 (RYR2) pathway and aggravates the accumulation of SUN1 in mutant iPSC-CMs, contributing to arrhythmias and NE deformation, respectively. Taken together, the lamin A/C deficiency-mediated ROS disorder is revealed as central to LMNA-DCM development. Manipulation of impaired SIRT1 activity and excessive oxidative stress is a potential future therapeutic strategy for LMNA-DCM., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF